AstraZeneca

Thumbnail for AstraZeneca announces setback in early-stage lung cancer drug imfinzi

25 June 2024

AstraZeneca announces setback in early-stage lung cancer drug imfinzi

Thumbnail for AstraZeneca completes acquisition of Fusion Pharmaceuticals for US$2.4B

7 June 2024

AstraZeneca completes acquisition of Fusion Pharmaceuticals for US$2.4B

Thumbnail for AstraZeneca expands Healthy Heart Africa to combat rising NCDs across Africa

29 May 2024

AstraZeneca expands Healthy Heart Africa to combat rising NCDs across Africa

Thumbnail for AstraZeneca to establish US$1.5B cancer drug manufacturing plant in Singapore

20 May 2024

AstraZeneca to establish US$1.5B cancer drug manufacturing plant in Singapore

Thumbnail for AstraZeneca withdraws COVID Vaccine globally

9 May 2024

AstraZeneca withdraws COVID Vaccine globally

Thumbnail for Angle partners with AstraZeneca for prostate cancer assay development

8 May 2024

Angle partners with AstraZeneca for prostate cancer assay development

Thumbnail for AstraZeneca acknowledges rare blood clot risk in COVID-19 vaccine

3 May 2024

AstraZeneca acknowledges rare blood clot risk in COVID-19 vaccine

Thumbnail for Ministry of Health, AstraZeneca join forces to make cancer care more affordable in Kenya

2 May 2024

Ministry of Health, AstraZeneca join forces to make cancer care more affordable in Kenya

Thumbnail for AstraZeneca strengthens rare disease portfolio with Voydeya approval

3 April 2024

AstraZeneca strengthens rare disease portfolio with Voydeya approval

Thumbnail for AstraZeneca bolsters rare disease portfolio with Amolyt Pharma acquisition

15 March 2024

AstraZeneca bolsters rare disease portfolio with Amolyt Pharma acquisition